Hypera Pharma (HYPE3)
BOV
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current HYPE3 market cap is 12.38B. The company's latest EPS is BRL 2.6017 and P/E is 7.51.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 2.65B | 2.58B | 2.3B | 2.21B | 2.62B |
| Operating Income | 734.13M | 735.84M | 512.03M | 579.4M | 687.18M |
| Net Income | 504.39M | 497.94M | 309.37M | 391.55M | 491.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 4.12B | 4.98B | 7.08B | 8.97B | 9.56B |
| Operating Income | 1.05B | 1.28B | 1.53B | 2.47B | 2.52B |
| Net Income | 1.16B | 1.3B | 1.33B | 1.7B | 1.65B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 0 | 0 | 0 | 0 | 0 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 11.92B | 17.25B | 19.82B | 23.76B | 24.51B |
| Total Liabilities | 3.21B | 8.01B | 9.98B | 13.1B | 12.99B |
| Total Equity | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 823.88M | 1.18B | 1.4B | 2.04B | 2.4B |
| Investing | -306.53M | -1.9B | -4.41B | -1.74B | -791.19M |
| Financing | 82.21M | 3.21B | 557.06M | 278.96M | -1.89B |
| Market Cap | 12.38B |
| Price to Earnings Ratio | 7.51 |
| Price to Sales Ratio | 1.29 |
| Price to Cash Ratio | 4.8 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 633.42M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (0.51%) |
| Company Name | Hypera Pharma |
| Address |
rua nova cidade, 404 bairro, vila olimpia sao paulo, sao paulo 04547 070 |
| Website | https://www.hypermarcas.com.br |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
